Variant report

Variant	esv2754280
Chromosome Location	chr11:55823576-55927591
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:149)
CpG islands
(count:671)
Chromatin interactive
region (count:3)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:149 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr11:55856682-55856750	K562	blood:	n/a	n/a
2	BACH1	chr11:55919802-55920154	H1-hESC	embryonic stem cell:	n/a	n/a
3	BACH1	chr11:55917916-55917973	H1-hESC	embryonic stem cell:	n/a	n/a
4	CEBPB	chr11:55823995-55824138	H1-hESC	embryonic stem cell:	n/a	n/a
5	CEBPB	chr11:55834333-55834597	HepG2	liver:	n/a	n/a
6	CEBPB	chr11:55906014-55906261	A549	lung:	n/a	n/a
7	CEBPB	chr11:55921214-55921534	HepG2	liver:	n/a	chr11:55921389-55921400
8	CEBPB	chr11:55828199-55828299	K562	blood:	n/a	n/a
9	CEBPB	chr11:55905952-55906317	MCF-7	breast:	n/a	n/a
10	CHD1	chr11:55861285-55861372	H1-hESC	embryonic stem cell:	n/a	n/a
11	CHD2	chr11:55824010-55824142	H1-hESC	embryonic stem cell:	n/a	n/a
12	CTCF	chr11:55857280-55857430	Caco-2	colon:	n/a	chr11:55857306-55857313
13	CTCF	chr11:55857222-55857410	A549	lung:	n/a	chr11:55857306-55857313
14	CTCF	chr11:55857315-55857414	K562	blood:	n/a	n/a
15	CTCF	chr11:55857278-55857489	H1-hESC	embryonic stem cell:	n/a	chr11:55857306-55857313
16	CTCF	chr11:55856583-55857666	A549	lung:	n/a	chr11:55857306-55857313
17	CTCF	chr11:55857339-55857418	HUVEC	blood vessel:	n/a	n/a
18	CTCF	chr11:55923930-55924003	GM13977	blood:	n/a	n/a
19	CTCF	chr11:55857380-55857530	BE2_C	brain:	n/a	n/a
20	CTCF	chr11:55857275-55857526	A549	lung:	n/a	chr11:55857306-55857313
21	CTCF	chr11:55857262-55857476	Medullo	brain:	n/a	chr11:55857306-55857313
22	CTCF	chr11:55857340-55857490	A549	lung:	n/a	n/a
23	CTCF	chr11:55857304-55857452	LNCaP	prostate:	n/a	chr11:55857306-55857313
24	CTCF	chr11:55835352-55835424	ProgFib	skin:	n/a	n/a
25	CTCF	chr11:55857282-55857482	IMR90	lung:	n/a	chr11:55857306-55857313
26	CTCF	chr11:55857328-55857425	GM20000	blood:	n/a	n/a
27	CTCF	chr11:55857301-55857439	GM13977	blood:	n/a	chr11:55857306-55857313
28	CTCF	chr11:55857297-55857435	LNCaP	prostate:	n/a	chr11:55857306-55857313
29	CTCF	chr11:55830312-55830375	GM13976	blood:	n/a	n/a
30	CTCF	chr11:55871069-55871124	GM13977	blood:	n/a	n/a
31	CTCF	chr11:55893760-55893910	NHDF-neo	bronchial:	n/a	n/a
32	CTCF	chr11:55857300-55857450	GM12801	blood:	n/a	chr11:55857306-55857313
33	CTCF	chr11:55890080-55890230	GM12866	blood:	n/a	n/a
34	CTCF	chr11:55904745-55904803	H1-hESC	embryonic stem cell:	n/a	n/a
35	CTCF	chr11:55857215-55857476	K562	blood:	n/a	chr11:55857306-55857313
36	CUX1	chr11:55878375-55878386	GM12878	blood:	n/a	n/a
37	CUX1	chr11:55909690-55909743	GM12878	blood:	n/a	n/a
38	E2F4	chr11:55908544-55908661	MCF10A-Er-Src	breast:	n/a	n/a
39	E2F4	chr11:55875913-55876332	MCF10A-Er-Src	breast:	n/a	n/a
40	E2F4	chr11:55913517-55913717	MCF10A-Er-Src	breast:	n/a	n/a
41	E2F4	chr11:55863942-55864132	MCF10A-Er-Src	breast:	n/a	n/a
42	FOXA1	chr11:55857176-55857491	T-47D	breast:	n/a	n/a
43	GATA2	chr11:55825179-55825528	K562	blood:	n/a	n/a
44	GATA3	chr11:55879288-55879577	SH-SY5Y	brain:	n/a	chr11:55879382-55879392 chr11:55879377-55879398 chr11:55879384-55879391 chr11:55879384-55879391 chr11:55879382-55879391 chr11:55879379-55879395 chr11:55879384-55879391
45	GTF2F1	chr11:55852135-55852147	H1-hESC	embryonic stem cell:	n/a	n/a
46	GTF2F1	chr11:55827611-55827650	H1-hESC	embryonic stem cell:	n/a	n/a
47	HDAC2	chr11:55825224-55825439	H1-hESC	embryonic stem cell:	n/a	n/a
48	IRF1	chr11:55878415-55878470	K562	blood:	n/a	n/a
49	JUN	chr11:55857434-55857453	H1-hESC	embryonic stem cell:	n/a	n/a
50	JUN	chr11:55856060-55856243	H1-hESC	embryonic stem cell:	n/a	n/a

(count:671 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:55872995-55873045	Jurkat	blood:	n/a
2	chr11:55889797-55889847	ovcar-3	ovarian:	n/a
3	chr11:55889797-55889847	Caco-2	colon:	n/a
4	chr11:55861503-55861553	HEEpiC	esophagus:	n/a
5	chr11:55872478-55872528	PANC-1	pancreas:	n/a
6	chr11:55861503-55861553	GM19239	blood:	n/a
7	chr11:55889808-55889858	HAEpiC	amniotic membrane:	n/a
8	chr11:55872478-55872528	AoSMC	blood vessel:	n/a
9	chr11:55889797-55889847	SAEC	small airway:	n/a
10	chr11:55872882-55872932	AG04449	skin:	fetal
11	chr11:55890274-55890324	HCF	heart:	n/a
12	chr11:55889808-55889858	NT2-D1	testis:	n/a
13	chr11:55872882-55872932	GM12892	blood:	n/a
14	chr11:55889658-55889708	GM12891	blood:	n/a
15	chr11:55890274-55890324	HEK293	kidney:	embryo
16	chr11:55889808-55889858	HL-60	blood:	n/a
17	chr11:55861503-55861553	T-47D	breast:	n/a
18	chr11:55890274-55890324	NHDF-neo	bronchial:	n/a
19	chr11:55872882-55872932	Hepatocyte	liver:	n/a
20	chr11:55872478-55872528	SKMC	muscle:	n/a
21	chr11:55889797-55889847	NT2-D1	testis:	n/a
22	chr11:55905246-55905296	NHBE	bronchial:	n/a
23	chr11:55889658-55889708	GM06990	blood:	n/a
24	chr11:55904782-55904832	HAEpiC	amniotic membrane:	n/a
25	chr11:55872882-55872932	ECC-1	luminal epithelium:	n/a
26	chr11:55905246-55905296	AG04449	skin:	fetal
27	chr11:55889808-55889858	SK-N-SH_RA	brain:	n/a
28	chr11:55890274-55890324	HCPEpiC	choroid plexus:	n/a
29	chr11:55889658-55889708	NB4	blood:	n/a
30	chr11:55872467-55872517	T-47D	breast:	n/a
31	chr11:55872882-55872932	NHDF-neo	bronchial:	n/a
32	chr11:55872467-55872517	BE2_C	brain:	n/a
33	chr11:55905246-55905296	HMEC	breast:	n/a
34	chr11:55872995-55873045	HRPEpiC	eye:	n/a
35	chr11:55904782-55904832	NT2-D1	testis:	n/a
36	chr11:55904782-55904832	HEK293	kidney:	embryo
37	chr11:55861503-55861553	HL-60	blood:	n/a
38	chr11:55872995-55873045	NT2-D1	testis:	n/a
39	chr11:55889797-55889847	AG09319	gingival:	n/a
40	chr11:55904782-55904832	K562	blood:	n/a
41	chr11:55890274-55890324	GM12891	blood:	n/a
42	chr11:55889658-55889708	AG04449	skin:	fetal
43	chr11:55889658-55889708	MCF-7	breast:	n/a
44	chr11:55872882-55872932	HCT-116	colon:	n/a
45	chr11:55872467-55872517	HepG2	liver:	n/a
46	chr11:55872995-55873045	HCM	heart:	n/a
47	chr11:55889797-55889847	HAEpiC	amniotic membrane:	n/a
48	chr11:55872995-55873045	Caco-2	colon:	n/a
49	chr11:55872478-55872528	U87	brain:	n/a
50	chr11:55904782-55904832	GM12891	blood:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr11:55861584..55863423-chr11:55907412..55909639,2	K562	blood:
2	chr11:55921059..55923391-chr11:55935211..55936757,2	K562	blood:
3	chr11:55861584..55863423-chr11:55907412..55909639,2	K562	blood:

No data

Variant related genes	Relation type
OR5BN2P	TF binding region
OR8I4P	TF binding region
OR8H2	TF binding region
OR8I2	TF binding region
OR8J3	TF binding region
OR8H3	TF binding region
OR5J1P	TF binding region
OR8K4P	TF binding region
OR5BE1P	TF binding region
OR5BN1P	TF binding region
OR5BN2P	CpG island
OR8I4P	CpG island
OR8H2	CpG island
OR8I2	CpG island
OR8J3	CpG island
OR8H3	CpG island
OR5J1P	CpG island
OR8K4P	CpG island
OR5BE1P	CpG island
OR5BN1P	CpG island

Extended variants
information (count: 811 )
Associated
traits (count: 51 )

Variant overlapped rSNPs/rCNVs (count:811 , 50 per page) page: 1 2 3 4 5 6 7 ... 17

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7106787	chr11:55823576-55823577	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs76302932	chr11:55823579-55823580	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs11827829	chr11:55823591-55823592	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs371899788	chr11:55823615-55823616	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs527525144	chr11:55823621-55823622	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs145286541	chr11:55823647-55823648	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs571819655	chr11:55823674-55823675	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs538847062	chr11:55823704-55823705	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs548115380	chr11:55823725-55823726	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs570445838	chr11:55823786-55823787	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs566220972	chr11:55823792-55823793	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs191093362	chr11:55823824-55823825	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs183285619	chr11:55823833-55823834	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs137874096	chr11:55823845-55823846	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs2512746	chr11:55823892-55823893	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs559086932	chr11:55823893-55823894	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs140931790	chr11:55823896-55823897	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs544857236	chr11:55823897-55823898	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs186528814	chr11:55823902-55823903	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs61891190	chr11:55823913-55823914	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs1842689	chr11:55823958-55823959	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs369324280	chr11:55823987-55823988	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs190580932	chr11:55823997-55823998	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs183183612	chr11:55824038-55824039	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs543152228	chr11:55824084-55824085	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs564826061	chr11:55824092-55824093	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs532768710	chr11:55824140-55824141	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs7110689	chr11:55824175-55824176	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs188260351	chr11:55824182-55824183	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs201920658	chr11:55824189-55824190	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs56014356	chr11:55824195-55824196	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs530437270	chr11:55824236-55824237	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs1384085	chr11:55824275-55824276	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs192546900	chr11:55824296-55824297	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs578069929	chr11:55824312-55824313	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs183296502	chr11:55824332-55824333	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs537439770	chr11:55824346-55824347	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs540867866	chr11:55824349-55824350	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs577481215	chr11:55824360-55824361	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs559037743	chr11:55824378-55824379	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs77708074	chr11:55824393-55824394	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs535086102	chr11:55824394-55824395	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs553708054	chr11:55824396-55824397	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs386753736	chr11:55824443-55824444	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs187475824	chr11:55824532-55824533	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs546203951	chr11:55824575-55824576	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs542524461	chr11:55824584-55824585	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs191357631	chr11:55824589-55824590	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs556770525	chr11:55824670-55824671	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs184617486	chr11:55824690-55824691	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:51)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Autism	22495311	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Renal cell carcinoma	18194544	CNVD
Glioblastoma multiforme	21138945	CNVD
Prostate cancer	18632612	CNVD
Esophageal cancer	21851588	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	17142309	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Myelofibrosis	22110671	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Glioblastoma multiforme	22286061	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	21637783	CNVD
Acute myeloid leukemia	16864856	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21484798	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Glioblastoma multiforme	19960244	CNVD
Liposarcoma	21253554	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Neuroblastoma	17533364	CNVD
Breast cancer	21364760	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Colorectal cancer	16272173	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Pituitary adenoma	18645599	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:56 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:55822200-55824800	Enhancers	ES-I3 Cell Line	embryonic stem cell
2	chr11:55822600-55823600	Enhancers	HUES48 Cell Line	embryonic stem cell
3	chr11:55822600-55823800	Enhancers	HUES64 Cell Line	embryonic stem cell
4	chr11:55822800-55824800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
5	chr11:55822800-55834000	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
6	chr11:55823000-55823800	Enhancers	HUES6 Cell Line	embryonic stem cell
7	chr11:55823400-55824000	Enhancers	iPS-20b Cell Line	embryonic stem cell
8	chr11:55823400-55824600	Enhancers	H1 Cell Line	embryonic stem cell
9	chr11:55823400-55825400	Enhancers	iPS-15b Cell Line	embryonic stem cell
10	chr11:55823600-55824000	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
11	chr11:55823800-55824000	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
12	chr11:55823800-55824400	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
13	chr11:55823800-55826000	Enhancers	iPS-18 Cell Line	embryonic stem cell
14	chr11:55824000-55824200	Enhancers	HUES48 Cell Line	embryonic stem cell
15	chr11:55824000-55824200	Enhancers	HUES6 Cell Line	embryonic stem cell
16	chr11:55824000-55824800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
17	chr11:55824000-55825000	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
18	chr11:55824200-55824400	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
19	chr11:55824200-55825000	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
20	chr11:55824400-55825200	Enhancers	HUES6 Cell Line	embryonic stem cell
21	chr11:55824400-55825200	Enhancers	HUES64 Cell Line	embryonic stem cell
22	chr11:55824600-55825800	Weak transcription	H1 Cell Line	embryonic stem cell
23	chr11:55824800-55826200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
24	chr11:55824800-55827200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
25	chr11:55825000-55825200	Active TSS	HUES48 Cell Line	embryonic stem cell
26	chr11:55825000-55825200	Active TSS	iPS-20b Cell Line	embryonic stem cell
27	chr11:55825200-55825400	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
28	chr11:55825200-55826000	Weak transcription	iPS-20b Cell Line	embryonic stem cell
29	chr11:55825200-55826200	Weak transcription	HUES48 Cell Line	embryonic stem cell
30	chr11:55825200-55828600	Weak transcription	HUES64 Cell Line	embryonic stem cell
31	chr11:55825400-55825800	Active TSS	HUES6 Cell Line	embryonic stem cell
32	chr11:55825400-55825800	Weak transcription	iPS-15b Cell Line	embryonic stem cell
33	chr11:55825800-55826800	Enhancers	iPS-15b Cell Line	embryonic stem cell
34	chr11:55825800-55827200	Weak transcription	HUES6 Cell Line	embryonic stem cell
35	chr11:55826000-55826200	Enhancers	H1 Cell Line	embryonic stem cell
36	chr11:55826000-55826400	Enhancers	iPS-20b Cell Line	embryonic stem cell
37	chr11:55826000-55827600	Weak transcription	iPS-18 Cell Line	embryonic stem cell
38	chr11:55826200-55826400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
39	chr11:55826200-55826400	Enhancers	HUES48 Cell Line	embryonic stem cell
40	chr11:55826400-55827600	Weak transcription	HUES48 Cell Line	embryonic stem cell
41	chr11:55826800-55828600	Weak transcription	iPS-15b Cell Line	embryonic stem cell
42	chr11:55827200-55827800	Enhancers	ES-I3 Cell Line	embryonic stem cell
43	chr11:55827200-55827800	Enhancers	HUES6 Cell Line	embryonic stem cell
44	chr11:55827600-55827800	Enhancers	iPS-18 Cell Line	embryonic stem cell
45	chr11:55827600-55829000	Enhancers	HUES48 Cell Line	embryonic stem cell
46	chr11:55827800-55828800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
47	chr11:55828600-55828800	Enhancers	HUES64 Cell Line	embryonic stem cell
48	chr11:55828600-55829000	Enhancers	iPS-15b Cell Line	embryonic stem cell
49	chr11:55828800-55829000	Enhancers	ES-I3 Cell Line	embryonic stem cell
50	chr11:55829000-55830000	Weak transcription	iPS-15b Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links